Search

everythinglearnresearchcommunity

for

Search:↓

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Male hormones affect oil-producing skin cells differently based on their body location, and the drug spironolactone can reduce these effects.

Androgen is important in controlling stem cell differentiation, reducing fat development, and increasing lean mass.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

The antiandrogen 11α-hydroxyprogesterone effectively reduces skin oil and cholesterol when applied to the skin.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

AR gene not major factor in female hair loss; different from male hair loss.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

TGF-β1 increases androgen receptor activity in hair loss, but Hic-5/ARA55 can counter this effect.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Oxidative stress, not insulin resistance, is significantly related to free androgen index in PCOS.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Androgen receptors found in monkey scalps, similar to humans, affect hair growth.

A woman with a rare adrenal tumor and hormonal disorder had improved testosterone levels after surgery, but her menstrual irregularities continued.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.

Certain gene variations are linked to better memory in healthy Chinese women.

Low serum ferritin levels are linked to hair loss in women.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

Chinese women with PCOS have higher androgen levels, which change with age and weight.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Glioblastoma cells can make androgens, which might help the tumor grow.